341 related articles for article (PubMed ID: 14501170)
1. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Ikeda F
Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
[TBL] [Abstract][Full Text] [Related]
2. [Antifungal activity and clinical efficacy of micafungin (funguard)].
Ikeda F
Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
[TBL] [Abstract][Full Text] [Related]
3. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
Wiederhold NP; Lewis JS
Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
5. Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.
Vehreschild JJ; Cornely OA
Future Microbiol; 2006 Aug; 1(2):161-70. PubMed ID: 17661660
[TBL] [Abstract][Full Text] [Related]
6. Micafungin.
Jarvis B; Figgitt DP; Scott LJ
Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
[TBL] [Abstract][Full Text] [Related]
7. Micafungin: a new echinocandin.
Chandrasekar PH; Sobel JD
Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
Ikeda F; Wakai Y; Matsumoto S; Maki K; Watabe E; Tawara S; Goto T; Watanabe Y; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Mar; 44(3):614-8. PubMed ID: 10681327
[TBL] [Abstract][Full Text] [Related]
9. In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2002 Dec; 50(6):1071-4. PubMed ID: 12461036
[TBL] [Abstract][Full Text] [Related]
10. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V; Petraitiene R; Groll AH; Roussillon K; Hemmings M; Lyman CA; Sein T; Bacher J; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1857-69. PubMed ID: 12019101
[TBL] [Abstract][Full Text] [Related]
11. Micafungin: pharmacology, experimental therapeutics and clinical applications.
Groll AH; Stergiopoulou T; Roilides E; Walsh TJ
Expert Opin Investig Drugs; 2005 Apr; 14(4):489-509. PubMed ID: 15882123
[TBL] [Abstract][Full Text] [Related]
12. Micafungin: a therapeutic review.
Higashiyama Y; Kohno S
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):345-55. PubMed ID: 15482200
[TBL] [Abstract][Full Text] [Related]
13. Micafungin sodium (FK-463).
Fromtling RA
Drugs Today (Barc); 2002 Apr; 38(4):245-57. PubMed ID: 12532193
[TBL] [Abstract][Full Text] [Related]
14. Role of micafungin in the antifungal armamentarium.
Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
[TBL] [Abstract][Full Text] [Related]
15. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of properties and clinical efficacy of the echinocandins.
Kim R; Khachikian D; Reboli AC
Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
[TBL] [Abstract][Full Text] [Related]
17. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
Tokimatsu I; Kushima H; Iwata A; Hashinaga K; Umeki K; Ohama M; Kohno K; Ishii H; Kishi K; Ogata M; Hiramatsu K; Saikawa T; Kadota J
Intern Med; 2007; 46(11):775-9. PubMed ID: 17541234
[TBL] [Abstract][Full Text] [Related]
18. Echinocandin antifungal drugs.
Denning DW
Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
[TBL] [Abstract][Full Text] [Related]
19. [Guidelines for the management of deep mycosis in neutropenic patients].
Yoshida M
Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):209-15. PubMed ID: 15550917
[TBL] [Abstract][Full Text] [Related]
20. Micafungin: a new echinocandin antifungal.
Joseph JM; Jain R; Danziger LH
Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]